Hurdles in Vaccine Development against Respiratory Syncytial Virus-Reference-Cited by-同舟云学术

Hurdles in Vaccine Development against Respiratory Syncytial Virus

Published:2019-10-30 Issue: Volume: Page:
ISSN:
Container-title:The Burden of Respiratory Syncytial Virus Infection in the Young
language:
Short-container-title:

Author:

Shafique Muhammad,Asif Zahoor Muhammad,Imran Arshad Muhammad,Aslam Bilal,Baker Siddique Abu,Hidayat Rasool Muhammad,Usman Qamar Muhammad,Usman Muhammad

Publisher

IntechOpen

Link

http://www.intechopen.com/download/pdf/68404

Reference121 articles.

1. Dowell SF, Anderson LJ, Gary HE Jr, Erdman DD, Plouffe JF, File TM Jr, et al. Respiratory syncytial virus is an important cause of community-acquired lower respiratory infection among hospitalized adults. The Journal of Infectious Diseases. 1996;174(3):456-462

2. Falsey AR, Hennessey PA, Formica MA, Cox C, Walsh EE. Respiratory syncytial virus infection in elderly and high-risk adults. The New England Journal of Medicine. 2005;352(17):1749-1759

3. Null DM, Bimle C, Weisman LE, Johnson K, Steichen J, Singh S, et al. Palivizumab, a humanized respiratory syncytial virus monoclonal antibody, reduces hospitalization from respiratory syncytial virus infection in high-risk infants. Pediatrics. 1998;102(3 Pt 1):531-537

4. Vandini S, Biagi C, Lanari M. Respiratory syncytial virus: The influence of serotype and genotype variability on clinical course of infection. International Journal of Molecular Sciences. 2017;18(8):pii.E1717. DOI: 10.3390/ijms18081717

5. Hacking D, Hull J. Respiratory syncytial virus—Viral biology and the host response. The Journal of Infection. 2002;45(1):18-24

Cited by 5 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Short hairpin RNA-mediated matrix gene silencing of human respiratory syncytial virus as a potent antiviral strategy;Future Virology;2023-04

2. Exploring different virulent proteins of human respiratory syncytial virus for designing a novel epitope-based polyvalent vaccine: Immunoinformatics and molecular dynamics approaches;2022-02-02

3. Revolutionizing polymer-based nanoparticle-linked vaccines for targeting respiratory viruses: A perspective;Life Sciences;2021-09

4. SETTING THE PRIORITIES RIGHT IN THE COVID-19 PANDEMIC;Qeios;2020-08-23

5. SETTING THE PRIORITIES RIGHT IN THE COVID-19 PANDEMIC;Qeios;2020-08-06